Efficacy and safety of ongericimab in patients with dyslipidemia: A GRADE-assessed systematic review and meta-analysis of randomized controlled trials.

Junshida (ongericimab) - Shanghai Junshi Biosci

http://www.ncbi.nlm.nih.gov/pubmed/41667319

Aamer Syed; Aizaz Anwar Khalid; Asad Jamal; Asim Shah; Hammad Iftikhar; Hammad Saif; Kamil Ahmad Kamil; Misbah Uddin; Mohamed Fawzi Hemida; Muhammad Jibran Afridi; Muhammad Waqas; Sajjad Ghanim Al Badri; Sidra Irfan; Suleman Khan; Zaryab Bacha

Feb 11, 2026